A Multifaceted Evaluation of a COVID-19 Contact Tracing Program in King County, Washington

Autor: Julia E, Hood, Rachel W, Kubiak, Tigran, Avoundjian, Eli, Kern, Meaghan, Fagalde, Hannah N, Collins, Elizabeth, Meacham, Megan, Baldwin, Richard J, Lechtenberg, Amy, Bennett, Christina S, Thibault, Sarah, Stewart, Jeffrey S, Duchin, Matthew R, Golden

Publikováno v: Journal of Public Health Management and Practice. 28:334-343

Despite the massive scale of COVID-19 case investigation and contact tracing (CI/CT) programs operating worldwide, the evidence supporting the intervention's public health impact is limited.To evaluate the Public Health-SeattleKing County (PHSKC) CI/

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e54bcb24fa64a6d9b1094576cf2446d
https://doi.org/10.1097/phh.0000000000001541

Differences in health-related quality of life between HIV-positive and HIV-negative people in Zambia and South Africa: a cross-sectional baseline survey of the HPTN 071 (PopART) trial

Autor: Dr Ranjeeta Thomas, PhD, Ronelle Burger, PhD, Abigail Harper, MSc, Sarah Kanema, BSc, Lawrence Mwenge, MSc, Nosivuyile Vanqa, MPhil, Nomtha Bell-Mandla, MPH, Prof Peter C Smith, MSc, Sian Floyd, MSc, Peter Bock, MRCPUK, Helen Ayles, PhD, Prof Nulda Beyers, PhD, Deborah Donnell, PhD, Sarah Fidler, PhD, Prof Richard Hayes, DSc, Katharina Hauck, PhD, James Hargreaves, Deborah Watson-Jones, Peter Godfrey-Faussett, Anne Cori, Mike Pickles, Nomtha Mandla, Blia Yang, Anelet James, Redwaan Vermaak, Nozizwe Makola, Graeme Hoddinott, Vikesh Naidoo, Virginia Bond, Musonda Simwinga, Alwyn Mwinga, Barry Kosloff, Mohammed Limbada, Justin Bwalya, Chepela Ngulube, Christophe Fraser, Susan Eshleman, Yaw Agyei, Vanessa Cummings, Denni Catalano, Lynda Emel, Lisa Bunts, Heather Noble, David Burns, Alain Kouda, Niru Sista, Ayana Moore, Rhonda White, Tanette Headen, Eric Miller, Kathy Hinson, Sten Vermund, Mark Barnes, Lyn Horn, Albert Mwango, Megan Baldwin, Shauna Wolf, Erin Hughes

Publikováno v: The Lancet Global Health, Vol 5, Iss 11, Pp e1133-e1141 (2017)

Background: The life expectancy of HIV-positive individuals receiving antiretroviral therapy (ART) is approaching that of HIV-negative people. However, little is known about how these populations compare in terms of health-related quality of life (HR

Externí odkaz: https://doaj.org/article/5e13a828ee5a49eaa7431d4f97d6547c

HOW CAN PATIENT PORTALS SUPPORT CAREGIVERS PROVIDING END-OF-LIFE CARE?: A MIXED-METHODS STUDY

Autor: Jennifer Dickman Portz, John David Powers, Megan Baldwin, Kathy Gleason, Rebecca Boxer, Ted Palen, Elizabeth Bayliss

Publikováno v: Innovation in Aging. 6:211-211

Patient portal design is rarely centered around patient caregivers—family members, friends and other designated persons who may access these digital tools for the patient’s health needs. This study examines: (a) portal features used by caregivers

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6ca1c88c78b50b0160c0bb71693d078c
https://doi.org/10.1093/geroni/igac059.842

Corneal avascularity is due to soluble VEGF receptor-1

Autor: Tejvir S. Khurana, Angela Orecchia, Lucy J. Leiper, Jayakrishna Ambati, Sakae Ikeda, Hans-Peter Gerber, Masabumi Shibuya, Yuichiro Ogura, Donna Kwan, Balamurali K. Ambati, Atsunobu Takeda, Judit Z. Baffi, Megan Baldwin, Napoleone Ferrara, B.J. Raisler, Michael T. Newcomb, Qing Lin, P. Jani, Judy St. Leger, Jassir Witta, J. Martin Collinson, Elizabeth Richter, Mark E. Kleinman, Eiji Sakurai, Tushar Suthar, David T. Curiel, Sandro De Falco, Don Samuelson, W. Richard Green, Romulo Albuquerque, Nirbhai Singh, Helene Marsh, Sasha Bogdanovich, Parameshwar J. Mahasreshti, Dalen W. Agnew, Miho Nozaki, Ruth B. Caldwell

Publikováno v: Nature (Lond.) 443 (2006): 993–997. doi:10.1038/nature05249
info:cnr-pdr/source/autori:Ambati B.K.; Nozaki M.; Singh N.; Takeda A.; Jani P.D.; Suthar T.; Albuquerque R.J.; Richter E.; Sakurai E.; Newcomb M.T.; Kleinman M.E.; Caldwell R.B.; Lin Q.; Ogura Y.; Orecchia A.; Samuelson D.A.; Agnew D.W.; St Leger J.; Green W.R.; Mahasreshti P.J.; Curiel D.T.; Kwan D.; Marsh H.; Ikeda S.; Leiper L.J.; Collinson J.M.; Bogdanovich S.; Khurana T.S.; Shibuya M.; Baldwin M.E.; Ferrara N.; Gerber H.P.; De Falco S.; Witta J.; Baffi J.Z.; Raisler B.J.; Ambati J./titolo:Corneal avascularity is due to soluble VEGF receptor-1/doi:10.1038%2Fnature05249/rivista:Nature (Lond.)/anno:2006/pagina_da:993/pagina_a:997/intervallo_pagine:993–997/volume:443

Corneal avascularity—the absence of blood vessels in the cornea—is required for optical clarity and optimal vision, and has led to the cornea being widely used for validating pro- and anti-angiogenic therapeutic strategies for many disorders1-4.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5895895d2d9645d1d550255ce89560d5
https://doi.org/10.1038/nature05249

Ocular distribution and pharmacokinetics of 125I-OPT302 and 125I-Aflibercept (EYLEA) following intravitreal administration to pigmented rabbits

Autor: A Tester, M. Gerometta, M Kreuger, Megan Baldwin, C Struble, J Prusakiewicz

Publikováno v: Acta Ophthalmologica. 92

Purpose OPT-302 is a soluble receptor that specifically and potently blocks VEGF-C and VEGF-D activity which are involved in the progression of retinal and corneal diseases. OPT-302 is currently under development for the treatment of wet AMD. The pur

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d18d0e0dfa63237464bc8c04d9545326
https://doi.org/10.1111/j.1755-3768.2014.f056.x